Clinical Trials List
2011-12-07 - 2014-06-30
Phase II
Terminated6
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林宗哲 Division of Thoracic Medicine
- 林育麟 Division of Thoracic Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- 廖唯昱 Division of Thoracic Medicine
- Chia-Chi Lin Division of Thoracic Medicine
- JIN-YUAN SHIH Division of Thoracic Medicine
- 蔡子修 Division of Thoracic Medicine
- Jih-Hsiang Lee Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蔡俊明 Division of Hematology & Oncology
- Yuh-Min Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Hung Chen Division of Thoracic Medicine
- 洪禎佑 Division of Thoracic Medicine
- Chien-Ying Liu Division of Thoracic Medicine
- 李立夫 Division of Thoracic Medicine
- Wen-Cheng Chang Division of Thoracic Medicine
- Chih-Liang Wang Division of Thoracic Medicine
- 吳振德 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳焜結 Division of Thoracic Medicine
- 楊宗顏 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Yen Tu Division of Thoracic Medicine
- Wei-Chun Chen Division of Thoracic Medicine
- Su-Tso Yang Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
264 participants